| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0304-3835(98)00019-6 |
| P698 | PubMed publication ID | 9683272 |
| P2093 | author name string | Schuster M | |
| Pietsch T | |||
| Weller M | |||
| Schabet M | |||
| P2860 | cites work | Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines | Q34182237 |
| Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation | Q34223630 | ||
| Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors | Q34377726 | ||
| A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor | Q34661010 | ||
| Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? | Q37364901 | ||
| Animal models of medulloblastomas and related primitive neuroectodermal tumors. A review. | Q40522500 | ||
| Primitive neuroectodermal tumors of the central nervous system in childhood: tumor biological aspects | Q40647174 | ||
| Chemotherapy for medulloblastomas and primitive neuroectodermal tumors | Q41118775 | ||
| Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis | Q41204766 | ||
| Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis | Q41347316 | ||
| A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay | Q41474027 | ||
| Absence of p53 mutations in childhood central nervous system primitive neuroectodermal tumors. | Q41535225 | ||
| Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express TrkA receptors | Q42804769 | ||
| The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables | Q48483676 | ||
| Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors | Q48673813 | ||
| Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics | Q48778469 | ||
| Preferential expression of Fas/APO1 (CD95) and apoptotic cell death in perinecrotic cells of glioblastoma multiforme | Q48879202 | ||
| The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis. | Q52207161 | ||
| Lipoxygenase inhibitors block CD95 ligand-mediated apoptosis of human malignant glioma cells. | Q55478434 | ||
| In vivo effects of recombinant human lymphotoxin on human medulloblastoma xenograft: enhancement of antitumor activity of etoposide. | Q55482467 | ||
| Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo | Q71708794 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | medulloblastoma | Q1333608 |
| P304 | page(s) | 121-126 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | CD95 ligand-induced apoptosis of human medulloblastoma cells | |
| P478 | volume | 128 |
| Q28588333 | Drm/Gremlin transcriptionally activates p21(Cip1) via a novel mechanism and inhibits neoplastic transformation |
| Q54033702 | Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression. |
| Q40319830 | TRAIL-induced apoptosis in U-1242 MG glioma cells |
Search more.